Response to sublingual immunotherapy with grass pollen extract: Monotherapy versus combination in a multiallergen extract

National Jewish Health, Denver, CO 80206, USA.
The Journal of allergy and clinical immunology (Impact Factor: 11.25). 07/2009; 124(1):150-156.e1-5. DOI: 10.1016/j.jaci.2009.04.037
Source: PubMed

ABSTRACT To date, there have been no randomized, double-blind studies showing the effectiveness of sublingual immunotherapy with multiple allergens.
The purpose of this study was to examine whether the efficacy of sublingual immunotherapy (SLIT) with standardized timothy extract was reduced by combination with other allergen extracts.
A single-center, randomized, double-blind, placebo-controlled trial with SLIT was conducted. After an observational grass season, SLIT was administered for 10 months to 54 patients randomized to 1 of 3 treatment arms: placebo, timothy extract (19 microg Phl p 5 daily) as monotherapy, or the same dose of timothy extract plus 9 additional pollen extracts. Symptom and medication scores were collected and titrated nasal challenges, titrated skin prick tests, specific IgE, IgG4 and cytokines release by timothy-stimulated lymphocyte proliferation were performed.
Perhaps because of a very low grass pollen season in 2008, there were no significant differences in medication or symptom scores in either treatment group compared with placebo. Compared with placebo, in the timothy monotherapy group, thresholds for titrated nasal challenge and skin prick tests (P = .03 and P = .001, respectively), and serum-specific IgG4 levels (P = .005) significantly increased, and IFN- gamma levels decreased (P = .02), whereas in the multiallergen group, there was significant improvement only in the titrated skin prick tests (P = .04) which was less than in the monotherapy group. There were no significant differences between the 2 active groups in any outcome measure, and both active groups experienced more adverse events than placebo. There were no systemic reactions.
Improvement in multiple relevant outcomes strongly suggests that SLIT with timothy extract alone was effective; however, the results for symptom and medication scores were not significant. The differences between multiple allergen SLIT and placebo only in skin sensitivity to timothy suggest a reduction in SLIT efficacy in this group. However, further studies are required to confirm these observations.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent reports of the prevalence of allergic rhinitis in the United States range from 20 to 40 % of the population. Typical symptoms can include nasal obstruction, rhinorrhea, sneezing, and conjunctivitis. Inhalant allergens, such as plant pollens, can cause seasonal symptoms, while perennial symptoms can be induced by dust mites, cockroaches, and certain molds. Allergen specific immunotherapy (SIT) is typically recommended for patients whose allergic rhinoconjunctivitis symptoms cannot be controlled by medications and environmental controls, cannot tolerate their medications, or desire an alternative to pharmacotherapy. While currently the only FDA approved form of SIT in the United States involves subcutaneous injection, sublingual immunotherapy is an alternative “off-label” form of allergen desensitization. This review article examines the efficacy and safety of sublingual immunotherapy for the treatment of allergic rhinitis.
    06/2013; 1(2). DOI:10.1007/s40136-013-0010-0
  • [Show abstract] [Hide abstract]
    ABSTRACT: The protospec unifies the concepts of requirements specification and prototype into a single software engineering process. An example of the use of the protospec concept for requirements specification within expert systems development domain is presented. The requirements specification resulting from this example is evaluated from both a user and a software engineering point of view. The result is compared to results for three other specification approaches
    System Sciences, 1989. Vol.II: Software Track, Proceedings of the Twenty-Second Annual Hawaii International Conference on; 02/1989
  • Electroencephalography and Clinical Neurophysiology 06/1995; 95(1):12P-12P. DOI:10.1016/0013-4694(95)94099-Z
Show more